INTRODUCTION
Tetrazoles and their derivatives have received great attention because of their wide range of therapeutic and biological properties.1,2 They have emerged as antibacterial,3-6 antiproliferation,7 anticancer,7 and anticonvulsant8 agents. In this article, it is our intention to enlarge the area of the investigation towards tetrazole framework and to evaluate antimicrobial activities.
RESULTS AND DISCUSSION
The reaction of ethyl 1-aminotetrazole-5-carboxylate (1) with hydrazine hydrate afforded the corresponding 1-aminotetrazole-5-carbohydrazide (2), which upon treating with carbon disulfide in pyridine catalyzed, gave 1-amino-5-(5-mercapto-1,3,4-oxadiazol-2-yl)tetrazole (3). The formation 5,9,10 of 3 from 2 was supported by elemental analyses and by the absence of absorption bands at 3200 and 1670 cm-1 for the respective stretching vibration of NH and CON in its IR spectrum. The acylation of 5-mercapto-1,3,4-oxadiazolyl structure 3 with chloroacetone or ethyl chloroacetate in ethanol containing anhydrous sodium acetate led to the direct formation of S-acylated 1,3,4-oxadiazolyl derivatives 4 and 5, respectively (Scheme 1).
The 1,3,4-oxadiazolyl 3 was also used5,11 to synthesize 1-amino-5-(4-amino-5-mercapto-1,2,4-triazol-3-yl)tetrazole (6) by its reaction with hydrazine hydrate. The mass spectrum of 6 showed molecular ion peak at 198.86 which was in agreement with molecular formula C3H5N9S (m/z = 199). The 4-amino-5-mercapto-1,2,4-triazolyl compound 6 was subjected to build a new 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivative 7 via the condensation with glacial acetic acid. The 1H NMR spectrum of 7 revealed the presence of signal characteristic of methyl group at 1.94 ppm. This assignment is in harmony with the reported results.5,12
5(4H)-Oxazolones represented13-16 an important class of heterocycles and interested in their chemistry and continues unabated because of their usefulness as synthons. Thus, diazotization of 1 with sodium nitrite in the presence of hydrochloric acid yielding the diazonium salt which on treating with hippuric acid and acetic anhydride mixture in the presence of sodium acetate trihydrate affording the ethyl 1-[N-(5-oxo-2-phenyloxazol-4-ylidene)-hydrazono] tetrazole-5-carboxylate (8).
The aminoester 1 was condensed with formamide to produce tetrazolo[5,1-f]-1,2,4-triazin-8(7H)one (9) which in turn was subjected to react with carbon disulfide in pyridine to give 8 (7H) thinone derivative 10. The 1H NMR spectrum revealed an exchangeable imino proton at 11.65 ppm and absence of SH proton signal, thus indicating its existence as the thione tautomer. The latter was reacted with chloroacetone or ethyl chloroacetate in ethanol containing anhydrous sodium acetate to provide the corresponding compounds 11 and 12. The thione 10 was also used to synthesize 8-hydrazino derivative 13 by its reaction with hydrazine hydrate.
Finally, the hydrazine 13 was converted into 1,2,4-triazolo[4,3-d]tetrazolo [5,1-f]-1,2,4-triazine derivatives 14 and 15 by refluxing with triethyl orthoformate or glacial acetic acid (Scheme 2). Elemental and spectra data of the latter compounds are consistent with the structure assigned to their compounds (cf. Experimental).
Scheme 1.(i) NH2NH2․H2O; (ii) CS2/ppyridine; (iii) ClCH2COR/CH3COONa; (iv) CH3COOH; (v) NaNO2/HCl; (vi) PhCONHCH2COOH/(CH3CO)2O/3COONa
Scheme 2.(i) HCONH2; (ii) CS2/ppyridine; (iii) ClCH2COR/3COONa; (iv) NH2NH2․H2O; (v) HC(OCH2CH3)3; (vi) CH3COOH
ANTIMICROBIAL ACTIVITY
Ten compounds were selected and evaluated in vitro for their antimicrobial properties against Gram- positive (Staphylococcus aureus) and Gram negative bacteria(Escherichia coli) in addition to a fungus (Candida albicans) microorganisms. The activities of these compounds were used for the determination 17,18 of antibacterials and antifungal activity is summarized in Table 1 showing that compounds 4, 7, 8, 10 and 15 exhibited activity comparable 25% of the ampicillin against S. aureus while the effect of 6,10 and 15 were 50% of the ampicillin against E. coli, the activity of 5 and 12 and both 4, 13 and 15 were 50% against C. albicans comparable to clotrimazole, respectively. The compound 3 possessed lower activity than the reference standards (ampicillin and clotrimazole) against the test organisms.
Table 1.Antimicrobial Activity of Synthesized Compounds (MIC in μg/mL)
EXPERIMENTAL
All melting points were determined in capillary tubes in a stuart scientific SMP1 apparatus. IR spectra were recorded on a satellite 1000 spectrophotometer using KBr wafer technique. 1H NMR spectra were obtained on a Varian Mercury VXR 3000 and Jeol ECA 500 spectrometers and chemical shifts are expressed in δ/ppm using TMS as an internal strandard. MS were recorded on a HP model MS-5988 spectrometer at electron ionizing energy of 70 eV. Microanalyses were performed by the Microanalytical Unit, Cairo University, Egypt. Compound 1 was synthesized19 from benzaldehyde hydrazone with ethyl triethoxyacetate in presence of sodium azide followed by hydrolysis with concentrated hydrochloric acid.
1-Aminotetrazole-5-carbohydrazide (2)
A mixture of 1.51 g 1 (0.01 mol) and 2 mL hydrazine hydrate was refluxed in 15 mL methanol for 3 h. The solid separated from the hot mixture was filtered off and recrystallized from methanol to give 1.23 g (89%) of 2; mp. 275 - 277 ℃; = 3400, 3350 (NH2), 3290 (NH), 1670 (CO) cm-1; 1H NMR (DMSO-d6): δ = 10.80 (s, 1H, NH), 5.74, 4.30 (2s, 2H each, 2NH2) ppm. Found: C,16.45; H, 3.30; N, 68.40%. C2H5N7O (143) required: C, 16.78; H, 3.50; N, 68.53%.
1-Amino-5-(5-mercapto-1,3,4-oxadiazol-2-yl) tetrazole (3)
A mixture of 1.12 g 2 (0.008 mol) and 5 mL carbon disulfide in 15 mL pyridine was heated on a water bath for 3 h, and then cooled. The separated product was filtered off, washed several times with ethanol and recrystallizred from methanol to give 1.15 g (79%) of 3; mp. 230 - 232 ℃; = 3390, 3350 (NH2), 2550 (SH), cm-1; 1H NMR (DMSO-d6): δ = 5.81 (s, 2H, NH2), 3.70 (s, 1H, SH) ppm. Found: C,19.22; H, 1.31; N, 53.22 %. C3H3N7OS (185) required: C, 19.46; H, 1.62; N, 52.97 %.
1-Amino-5(5-acetonylthio-1,3,4-oxadiazol-2-yl) tetrazole (4)
A mixture of 0.72 g 3 (0.004 mol) and 0.36 g chloroacetone (0.004 mol) in 15 mL ethanol containing 2 g anhydrous sodium acetate was refluxed for 1 h. After cooling, the collected product was filtered off, washed with water and recrystallized from methanol to yield 0.53 g (56%) of 4, mp. 220 - 222 ℃; = 3400, 3350 (NH2), 1750 (CO) cm-1; 1H NMR (DMSO-d6): δ= 5.70 (s, 2H, NH2), 4.25 (s, 2H, CH2), 2.30 (s, 3H, CH3) ppm; MS: m/z (%) = 242 (M+ + 1, 28). Found : C, 30.22; H, 3.23; N, 40.43%. C6H7N7O2S (241) required: C, 29.88; H, 2.91; N, 40.66%.
1-Amino-5-(5-ethoxycarbonylmethylthio-1,3,4-oxadiazol-2-yl) tetrazole (5)
Compound 5 was prepared form 3 0.54 g (0.003 mol) and 0.40 g ethyl chloroacetate (0.003 mol) as previously described for the preparation of 4. It was crystallized from methanol, yield 0.47 g (60%) mp. 214 - 216 ℃; = 3480, 3380 (NH2), 1770 (CO) cm-1; 1H NMR (DMSO-d6): δ = 5.72 (s, 2H, NH2), 4.40 (q, 2H, CH2), 4.25 (s, 2H, CH2), 1.25 (t, 3H, CH3) ppm. Found: C, 31.44; H, 3.62; N, 35.84%, C7H9N7O3S (271) required: C, 31.00; H, 3.32; N, 36.16.
1-Amino-5-(4-amino-5-mercapto-1,2,4-triazol-3-yl) tetrazole (6)
A solution of 0.54 g 3 (0.003 mol), in ethanol 15 mL, was treated with hydrazine hydrate (95%, 5 mL) was refluxed for 2 h, diluted with cold water, and acidified by hydrochloric acid. The precipitated product was filtered, washed with water, and recrystallized from methanol to afford 0.37 g (64%) of 6; mp. 245 - 247 ℃; = 3390, 3350 (NH2), 2600 (SH) cm-1; 1H NMR (DMSO-d6): δ = 5.81, 5.74 (2s, 2H each, 2NH2), 3.92 (s, 1H, SH) ppm; MS: m/z (%) = 198.86 (M+, 17), Found: C,17.81; H, 2.94; N, 63.45%. C3H5N9S (199) required: C, 18.09; H, 2.51, N, 63.32%.
3-(1-Aminotetrazol-5-yl)-6-methyl-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole (7)
A mixture of aminothiol 0.61g 6 (0.003 mol) and glacial acetic acid 10 mL was refluxed for 1 h. The mixture was evaporated under reduced pressure, and the obtained residue was crystallized from methanol to give 0.41 g (60%) of 7; mp. 260 - 261 ℃; = 3380, 3355 (NH2) cm-1; 1H NMR (DMSO-d6): δ = 5.78 (s, 2H, NH2), 1.94 (s, 3H, CH3) ppm; MS: m/z (%) = 224 (M+ + 1, 30). Found C, 27.11; H. 2.65; N, 56.44% . C5H5N9S(223) required: C, 26.91; H, 2.24; N, 56.50%.
Ethyl 1-[N-(5-oxo-2-phenyloxazol-4-ylidene)-hydrazono] tetrazole-5-carboxylate (8)
A solution of aminoester 1.48 g 1 (0.009 mol) in glacial acetic acid 20 mL and concentrated hydrochloric acid 5 mL was cooled in an ice-salt bath and diazotized with sodium nitrile 0.65 g. Sodium acetate trihydrate 1.28 g was added, followed by a freshly prepared solution of hippuric acid 1.69 g (0.009 mol) in acetic anhydride 10 mL, which added rapidly, with heating at 90 ℃ for 2 h. The mixture was cooled, almost completely precipitated within 2 h, filter the formed solid and recrystallized methanol to yield 2.54 g (82%) orange crystals of 8; mp. 190 - 191 ℃; = 3279 (NH), 1774, 1712 (CO) cm-1; 1H NMR (DMSO-d6): δ= 10.28 (s, 1H, exchangeable with D2O, NH), 8.21-7.42 (m, 5H, ArH), 4.15 (q, 2H, CH2), 1.35 (t, 3H, CH3) ppm. MS: m/z (%) = 330 (M+ + 1, 16.3). Found: C, 47.64; H, 3.21; N, 30.22%. C13H11N7O4 (329) required: C, 47.42; H, 3.34; N, 29.79%.
Tetrazolo[5,1-f]-1,2,4-triazin-8-(7H)-one (9)
A solution of 2.23 g 1 (0.01 mol) in 10 mL formamide was refluxed for 2 h. The solid product which separated from the mixture was filtered off and recrystallized from methanol to yield 0.84 g (78%) of 9, mp. 230 - 231 ℃; = 3260 (NH), 1670 (CO) cm-1; 1H NMR (DMSO-d6): δ= 10.28 (s, 1H, exchangeable with D2O, NH), 8.21-7.42 (m, 5H, ArH), 4.15 (q, 2H, CH2), 1.35 (t, 3H, CH3) ): δ = 11.81 (s, 1H, exchangeable with D2O, NH), 6.22 (s, 1H, CH) ppm; MS: m/z (%) = 138 (M+, 7.4). Found : C, 25.88; H, 1.92; N, 61.01%. C3H2N6O (138) required: C, 26.09; H, 1.45; N, 60.87%.
Tetrazolo[5,1-f]-1,2,4-triazin-8(7H)-thione (10)
A mixture of 0.52 g 9 (0.004 mol) and 5 mL carbon disulfide in 15 mL pyridine was heated under reflux for 3 h, and then cooled at ambient temperature, poured onto ice-water, the crude solid that precipitated was filtered, washed with water and recrystallized from methanol to produce 0.44 g (76%) yellow crystrals of 10; mp. 220 - 222 ℃; = 3227 (NH), 1176 (CS) cm-1; 1H NMR (DMSO-d6): δ = 11.65 (s, 1H, exchangeable with D2O, NH), 5.92 (s, 1H, CH) ppm. Found : C, 23.21; H, 1.56; N, 54.98%. C3H2N6S (154) required: C, 23.38; H, 1.30; N, 54.55%.
8-Acetonylthiotetrazolo[5,1-f]-1,2,4-triazine (11)
A mixture of 0.32 g 10 (0.002 mol) and 0.19 g chloroacetone (0.002 mol) in 15 mL ethanol containing 2 g anhydrous sodium acetate was refluxed for 1 h. After cooling, the solid product was filtered off, washed with water and recrystallized from methanol to give 0.31g (71%) of 11; mp. 205 - 207 ℃ ; = 1740 (CO) cm-1; 1H NMR (DMSO-d6): δ = 6.15 (s, 1H, CH), 4.30 (s, 2H, CH2), 2.25 (s, 3H, CH3) ppm. Found: C, 34.61; H, 3.02; N, 40.36%.
8-Ethoxycarbonylmethylthiotetrazolo[5,1-f]-1,2,4-triazine (12)
Compound 12 was prepared from 10 0.21g (0.001 mol) and 0.19 g ethyl chloroacetate (0.001 mol) as just described for the preparation of 11. It was crystallized from methanol, yield 0.19 g (61%) mp. 195 - 196 ℃; = 1770 (CO) cm-1; 1H NMR (DMSO-d6): δ = 5.92 (s, 1H, CH), 4.45 (q, 2H, CH2), 4.20 (s, 2H, CH2), 1.30 (t, 3H, CH3) ppm; MS: m/z (%) = 224 (M+; 16.2). Found : C, 37.41; H, 3.82; N, 38.01%. C7H8N6OS (224) required: C, 37.50; H, 3.57; N, 37.50%.
8-Hydrazinotetrazolo[5,1-f]-1,2,4-triazine (13)
A mixture of 0.41 g 10 (0.003 mol) and hydrazine hydrate (95%, 5 mL) in 15 mL ethanol was refluxed for 2 h and then left to cool, diluted with water, and acidified with hydrochloric acid. The mass product was filtered, washed with water, and recrystallized from methanol to give 0.31 g (77%) of 13; mp. 190 - 192 ℃; = 3460, 3380 (NH2), 3200 (NH) cm-1; 1H NMR (DMSO-d6): δ = 11.25 (s, 1H, NH), 5.90 (s, 1H, CH), 4.32 (br s, 2H, NH2) ppm. Found: C, 24.12; H, 2.42; N, 74.02%. C3H4N8 (152) required: C, 23.68; H, 2.63; N, 73.68%.
1,2,4-Triazolo[4,3-d]tetrazolo[5,1-f]-1,2,4-triazine (14)
A mixture of 0.22 g 13 (0.001 mol) and 5 mL triethyl orthoformate was heated at reflux for 2 h and then evaporated under reduced pressure. The obtained residue was crystallized from methanol to yield 0.12 g (52%) of 14; mp. 235 - 237 ℃; 1H NMR (DMSO-d6): δ = 6.02, 5.80 (2 s, 1H each, 2 CH); MS: m/z (%) = 163 (M+ + 1, 26.7). Found: C, 29.21; H, 1.56; N, 68.82%. C4H4N4 (162) required: C, 29.63; H, 1.24; N, 69.14%.
8-Methyl-1,2,4-triazolo[4,3-d]tetrazolo [5,1-f]-1,2,4-triazine (15)
A mixture of of 0.26 g 13 (0.002 mol) and glacial acetic acid 10 mL was refluxed for 1h. The mixture was evaporated under reduced pressure, and the resulted residue was crystallized from methanol to give 0.16 g (53%) of 15; mp. 219 - 221 ℃; 1H NMR (DMSO-d6): δ = 6.14 (s, 1H, CH), 2.40 (s, 3H, CH3) ppm; MS: m/z (%) = 176 (M+; 29). Found: C, 33.89; H, 2.51; N, 64.01%. C5H4N8 (176) required: C, 34.09; H, 2.27; N, 63.64%.
BIOLOGICAL SCREENING
The screened compounds, ampicillin trihydrate and clotrimazole were dissolved in DMSO at concentration 1600 μg/mL. The minimal inhibitory concentrations (MIC) were measured in μg/mL at the end of the incubation period for 24 to 48 h at 36 ℃. Controls for the DMSO microorganisms and media microorganisms were also undertaken.
참고문헌
- Moderhack, D. J. Prakt. Chem. 1998, 340, 687. https://doi.org/10.1002/prac.19983400802
- Kolodobskii, G. I.; Ostrovskii, V. A.; Popavskii, V. S. Chem. Heterocycl. Cpds. 1981, 17, 965. https://doi.org/10.1007/BF00503523
- Taha, M. A. M. Monatsh. Chem. 2007, 138, 505. https://doi.org/10.1007/s00706-007-0599-0
- Taha, M. A. M.; El-Badry, S. M. Monatsh. Chem. 2008, 139, 1261. https://doi.org/10.1007/s00706-008-0902-8
- Taha, M. A. M.; El-Badry, S. M. Phosphorus, Sulfur, Silicon 2007, 182, 1011. https://doi.org/10.1080/10426500601090768
- Karnik, A. V.; Malviya, N. J.; Kulkarni, A. M.; Jadhav, B. L. Eur. J. Med. Chem. 2006, 41, 891. https://doi.org/10.1016/j.ejmech.2006.01.018
- Jantova, S.; Ruzekova, L.; Stantovsky, S.; Spirkova, K. Neoplasma 1997, 44, 240.
- Rubat, C.; Coudert, P.; Couquelet, J. M.; Tronche P.; Bastide, J.; Bastide, P. Farmaco 1990, 45, 331.
- Pramanik, S. S.; Mukherjee, A. J. Indian Chem. Soc. 1998, 75, 53.
- Abdel-Mohsen, S. A.; Geies, A. A. Monatsh. Chem. 2008, 139, 1233. https://doi.org/10.1007/s00706-007-0839-3
- Reid, J. R.; Heindel, N. D. J. Heterocycl. Chem. 1976, 13, 925. https://doi.org/10.1002/jhet.5570130450
- Taha, M. A. M. Phosphorus, Sulfur, Silicon 2008, 183, 2525. https://doi.org/10.1080/10426500801967773
- Harhash, A. H.; Kassab, N. A. L.; Banani, A. A. Indian J. Chem. 1971, 9, 789.
- Kevin, J.; Mark, T. K. Organic Lett. 2002, 4, 2905. https://doi.org/10.1021/ol0262800
- Guella, G.; Ndiaye, I.; Fofana, M.; Mancini, I. Tetrahedron 2005, 62, 1165. https://doi.org/10.1016/j.tet.2005.10.072
- Pozgan, F.; Kranjc, K.; Kepe, V.; Polanc, S.; Kocevar, M. Arkivoc 2007, viii, 97.
- Murray, P. R.; Baron, E. J.; Pfaller, M. A.; Tenover, F. C.; Yolken, R. H. In Antimicrobial Agents and Susceptibility Testing; Woods, G. L., Washington, J. A., Eds.; American Society Microbiology; Washington: DC, 1995, 6th ed., p 1327.
- Arthington, B. A.; Motley, M.; Warnock, D. W.; Morrison, C. J. J. Clin. Microbiology 2000, 38, 2254.
- Gaponik, P. N.; Karavai, V. P. Chem. Heterocycl. Compds. 1983, 19, 681. https://doi.org/10.1007/BF00523087
피인용 문헌
- Novel and Efficient Synthesis of Tetrazolo[1,5-b]-1,2,5-oxadiazepines as Antibacterial Activities from Ethyl 1-aminotetrazole-5-carboxylate vol.55, pp.6, 2011, https://doi.org/10.5012/jkcs.2011.55.6.974
- Synthesis of tetrazole and its derivatives by heterocyclization reaction involving primary amines, orthoesters, and azides vol.53, pp.6-7, 2017, https://doi.org/10.1007/s10593-017-2108-7
- Synthesis of Some Novel N7-tetrazolo[5,1-f]-1,2,4-triazin-8-(7H)-one Compounds as Potential Antimicrobial Agents vol.58, pp.4, 2014, https://doi.org/10.5012/jkcs.2014.58.4.381
- Design and synthesis of 2-Substituted-4-benzyl-5-methylimidazoles as new potential Anti-breast cancer agents to inhibit oncogenic STAT3 functions vol.113, pp.None, 2010, https://doi.org/10.1016/j.bioorg.2021.105033
- Naphthalen-2-yl 1-(benzamido(diethoxyphosphoryl)methyl)-1H-1,2,3-triazole-4-carboxylate vol.2021, pp.4, 2010, https://doi.org/10.3390/m1285